IndraLab

Statements

USP39 activates Carcinoma, Renal Cell. 1 / 1

| 1

reach

"USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A 165b alternative splicing via regulating SRSF1 and SRPK1."

34544400

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP39 activates Carcinoma, Renal Cell. 1 / 1

INDRA sources:

Databases

Reading